Nanobiotix Files May 2025 Report on Form 6-K
Ticker: NBTX · Form: 6-K · Filed: May 5, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, 6-K, foreign-private-issuer
TL;DR
NANO filed its monthly 6-K, standard procedure, check 20-F for annuals.
AI Summary
Nanobiotix S.A. filed a Form 6-K on May 5, 2025, to report its activities for the month of May 2025. The company, a pharmaceutical preparations firm, is based in Paris, France, and is required to file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates on Nanobiotix's corporate activities, which is important for investors to stay informed about the company's ongoing compliance and reporting.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that does not contain new material financial or operational information, indicating low immediate risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the report
- 001-39777 (company) — SEC File Number
- 20250505 (date) — Filing date
- May 2025 (date) — Reporting period
- 60 Rue de Wattignies 75012 Paris, France (location) — Principal executive office address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is Nanobiotix S.A.'s standard annual reporting form?
Nanobiotix S.A. files its annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on May 5, 2025.
What is the principal executive office of Nanobiotix S.A.?
The principal executive office of Nanobiotix S.A. is located at 60 Rue de Wattignies, 75012 Paris, France.
Does Nanobiotix S.A. have any specific reporting obligations for May 2025 mentioned in this filing?
This Form 6-K is filed for the month of May 2025 and indicates Nanobiotix S.A.'s reporting activities during that period.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding Nanobiotix S.A. (NBTX).